Published • loading... • Updated
Sweden’s Acorai bags €4.2M to advance heart failure management devices
Summary by Silicon Canals
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Sweden’s Acorai bags €4.2M to advance heart failure management devices
Helsingborg-based Acorai, a Swedish company specialising in heart failure management devices, announced that it secured $4.5M (approximately €4.28M) in a fresh round of funding. The investment, made by the European Innovation Council (EIC) Fund, Taiwan Medical University, and private investors, will support the completion of clinical studies and regulatory approvals in the US and Europe. Earlier this year, in January 2024, Acorai closed an over…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
